Since its public debut in January of this year, ARMO Biosciences Inc. (ARMO) has gained more than 50% in sharp contrast to the iShares NASDAQ Biotechnology Index's (ETF)(IBB) measly return of 1.23%.
from RTT - Biotech http://ift.tt/2F68jnv
via IFTTT
No comments:
Post a Comment